References
- Bae S, Lee E-J, Lee JH, et al. Oridonin protects HaCaT keratinocytes against hydrogen peroxide-induced oxidative stress by altering microRNA expression. Int J Mol Med 2014;33:185–193.
- Guo W, Zheng P, Zhang J, et al. Oridonin suppresses transplant rejection by depleting T cells from the periphery. Int Immunopharmacol 2013;17:1148–1154.
- Yang R, Huang X, Dou J, et al. Self-microemulsifying drug delivery system for improved oral bioavailability of oleanolic acid: design and evaluation. Int J Nanomedicine 2013;8:2917–2926.
- Qi X, Zhang D, Xu X, et al. Oridonin nanosuspension was more effective than free oridonin on G2/M cell cycle arrest and apoptosis in the human pancreatic cancer PANC-1 cell line. Int J Nanomedicine 2012;7:1793–1804.
- Wang W, Zhu R, Xie Q, et al. Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int J Nanomedicine 2012;7:3667–3677.
- Phan S, Fong W-K, Kirby N, et al. Evaluating the link between self-assembled mesophase structure and drug release. Int J Pharm 2011;421:176–182.
- de Waard H, De Beer T, Hinrichs WL, et al. Controlled crystallization of the lipophilic drug fenofibrate during freeze-drying: elucidation of the mechanism by in-line Raman spectroscopy. AAPS J 2010;12:569–575.
- Dian L, Yang Z, Li F, et al. Cubic phase nanoparticles for sustained release of ibuprofen: formulation, characterization, and enhanced bioavailability study. Int J Nanomedicine 2013;8:845–854.
- Zhang Z, Gao F, Jiang S, et al. Nano-based drug delivery system enhances the oral absorption of lipophilic drugs with extensive presystemic metabolism. Curr Drug Metab 2012;13:1110–1118.
- Esposito E, Eblovi N, Rasi S, et al. Lipid-based supramolecular systems for topical application: a preformulatory study. AAPS PharmSci 2003;5:62–76.
- Hartmann P, Lee D-K, Smarsly BM, et al. Mesoporous TiO(2): comparison of classical sol-gel and nanoparticle based photoelectrodes for the water splitting reaction. ACS Nano 2010;4:3147–3154.
- Boyd BJ, Khoo S-M, Whittaker DV, et al. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats. Int J Pharm 2007;340:52–60.
- Chang C-M, Bodmeier R. Low viscosity monoglyceride-based drug delivery systems transforming into a highly viscous cubic phase. Int J Pharm 1998;173:51–60.
- Muller F, Salonen A, Glatter O. Phase behavior of phytantriol/water bicontinuous cubic Pn3m cubosomes stabilized by laponite disc-like particles. J Colloid Interface Sci 2010;342:392–398.
- Korjamo T, Heikkinen AT, Monkkonen J. Analysis of unstirred water layer in in vitro permeability experiments. J Pharm Sci 2009;98:4469–4479.
- Swarnakar NK, Thanki K, Jain S. Bicontinuous cubic liquid crystalline nanoparticles for oral delivery of doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicity. Pharm Res 2014;31:1219–1238.
- Jain S, Bhankur N, Swarnakar NK, Thanki K. Phytantriol based “stealth” lyotropic liquid crystalline nanoparticles for improved antitumor efficacy and reduced toxicity of docetaxel. Pharm Res 2015;32:1–11.
- Chang DP, Jankunec M, Barauskas J, et al. Adsorption of lipid liquid crystalline nanoparticles on cationic, hydrophilic, and hydrophobic surfaces. ACS Appl Mater Interfaces 2012;4:2643–2651.
- Nguyen T-H, Hanley T, Porter CJ, et al. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration. J Control Release 2011;153:180–186.
- Rizwan S, Dong Y-D, Boyd B, et al. Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM). Micron 2007;38:478–485.
- Yang D, Armitage B, Marder SR. Cubic liquid-crystalline nanoparticles. Angew Chem Int Ed Engl 2004;43:4402–4409.
- Jia L, Shen J, Zhang D, et al. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers. Int J Biol Macromol 2012;50:523–529.
- Gao L, Zhang D, Chen M, et al. Preparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancement. Drug Dev Ind Pharm 2007;33:1332–1339.
- Hancock BC, Carlson GT, Ladipo DD, et al. Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substance. Int J Pharm 2002;241:73–85.
- Schoen. Infinite periodic minimal surfaces without self-intersection, NASA Technical Note C-98 (NASA Electronics Research Center, Cambridge, Mass., Sept. 1969); NASA Technical Note 1970;D-5541, Notices of the Amer Math Soc 1969;16;519, 1968;15;929, 1968;15;727, 1967;14;661.
- Han K, Pan X, Chen M, et al. Phytantriol-based inverted type bicontinuous cubic phase for vascular embolization and drug sustained release. Eur J Pharm Sci 2010;41:692–699.
- Shah JC, Sadhale Y, Chilukuri DM. Cubic phase gels as drug delivery systems. Adv Drug Deliv Rev 2001;47:229–250.
- Barry PH, Diamond JM. Effects of unstirred layers on membrane phenomena. Physiol Rev 1984;64:763–872.
- Larhed AW, Artursson P, Björk E. The influence of intestinal mucus components on the diffusion of drugs. Pharm Res 1998;15:66–71.
- Barauskas J, Johnsson M, Tiberg F. Self-assembled lipid superstore beyond vesicles and liposomes. Nano Lett 2005;5:1615–1619.